Gonorrhea Archives - Infectious Disease Advisor

Efficacy of Ceftriaxone Monotherapy Comparable to Dual Therapy for Extragenital Gonorrhea

By

July 2, 2021

Investigators compared with efficacy of high-dose ceftriaxone monotherapy against that of dual therapy for Neisseria gonorrhoeae in men who have sex with men.

The Centers for Disease Control and Prevention (CDC) offers a wide range of apps for health care professionals and patients alike. One seasonally appropriate standout is CDC Influenza (Flu): created for clinicians. The CDC Influenza application provides up-to-date information on flu activity across the nation, vaccination recommendations, and diagnosis and treatment guidance from the Advisory Committee on Immunization Practices (ACIP).

General Infectious Disease

CDC: US STD Rate at Record High Again

April 20, 2021

Early data from 2020 shows about 2.5 million cases of chlamydia, gonorrhea, and syphilis in 2019, which is an almost 30% increase in these STDs between 2015 and 2019.

General Infectious Disease

Universal Testing Necessary to Detect Oropharyngeal Gonorrhea Infections

By

Sweta Gupta

April 14, 2021

Researchers assessed the optimal testing strategy for oropharyngeal N gonorrhoeae using surveillance data from all sexually transmitted infection clinics.

Sexually Transmitted Diseases

Single-Drug Regimen Now Advised for Uncomplicated Gonorrhea

January 25, 2021

A single 500 mg intramuscular dose of ceftriaxone is recommended for treatment of uncomplicated urogenital, anorectal, and pharyngeal gonorrhea.

Genitourinary

Distribution and Spread of Susceptible and Resistant Gonorrhea in New York City

By

Bradley van Paridon

September 9, 2020

Isolates were clustered based on patient sexual behavior and race/ethnicity to assess antibiotic resistance as a major driver of gonorrhea transmission in NYC.

Genitourinary

Caution Required When Using Supplementary Nucleic Acid Amplification Tests for Gonorrhea

By

Zahra Masoud

September 3, 2020

Research results highlighted the need for continued supplemental NAATs for oropharyngeal samples being tested for Nisseria gonorrhoeae.

Genitourinary

Serine 91 Genotype of gyrA Gonorrhea Successfully Treated With Ciprofloxacin

August 14, 2020

For patients with gonorrhea, detection of the wild-type serine 91 genotype of the gyrA gene of Neisseria gonorrhoeae is predictive of a successful treatment outcome with ciprofloxacin.

Sexually Transmitted Diseases